Private Advisor Group, LLC Catalent, Inc. Transaction History

Private Advisor Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$32.18 - $46.57 $51,359 - $74,325	-1,596 Reduced 25.14%	4,753 $213,000
Q3 2023 Nov 02, 2023	BUY	$44.2 - $50.2 $42,564 - $48,342	963 Added 17.88%	6,349 $289,000
Q2 2023 Aug 09, 2023	BUY	$31.86 - $67.26 $10,959 - $23,137	344 Added 6.82%	5,386 $233,000
Q1 2023 May 10, 2023	BUY	$45.44 - $74.26 $229,108 - $374,418	5,042 New	5,042 $331,000
Q2 2022 Jul 13, 2022	BUY	$87.2 - $114.05 $254,013 - $332,227	2,913 Added 98.51%	5,870 $630,000
Q1 2022 May 12, 2022	BUY	$94.19 - $124.49 $42,573 - $56,269	452 Added 18.04%	2,957 $328,000
Q4 2021 Feb 10, 2022	SELL	$119.57 - $139.07 $229,574 - $267,014	-1,920 Reduced 43.39%	2,505 $320,000
Q3 2021 Oct 14, 2021	BUY	$109.17 - $142.35 $483,077 - $629,898	4,425 New	4,425 $589,000
Q1 2020 May 12, 2020	SELL	$36.95 - $62.95 $186,930 - $318,464	-5,059 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$47.06 - $56.64 $423 - $509	-9 Reduced 0.18%	5,059 $285,000
Q3 2019 Nov 13, 2019	BUY	$47.45 - $58.05 $240,476 - $294,197	5,068 New	5,068 $242,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.